Circadian Rhythm Sleep Treatment Market Size, Share and Forecast 2026
The Circadian Rhythm Sleep Treatment market was worth the US $XX billion in 2018 and is forecasted to reach US $XX billion by 2026, at a CAGR of XX% during the forecast period.
(EMAILWIRE.COM, September 13, 2019 ) Market Overview:
Circadian rhythm sleep disorders (CRSD) are sleep disorders which affect the timing of sleep. CRSDs arise from a persistent pattern of sleep/wake disturbances that can be caused either by dysfunction in one's biological clock system or by a misalignment between one's endogenous oscillator and externally imposed cues. The primary event in circadian rhythm sleep treatment is depression of melatonin level and irregular melatonin level during the circadian body clock.
Market Dynamics:
Increasing prevalence of sleep disorders is boosting the global circadian rhythm sleep treatment market. However, some side effects such as dizziness, headache, short-term feelings of depression, daytime sleepiness, stomach cramps, and irritability. These factors are hampering the global circadian rhythm sleep treatment market.
Market Segmentation:
By Treatment Type
• Light Therapy
• Drug Therapy
• Chronotherapy
By Disorder
• Delayed Sleep Phase Syndrome (DSPS)
• Advanced Sleep Phase Syndrome (ASPS)
• Irregular Sleep-Wake Disorder (ISWD)
• Non-24-h Sleep-Wake Syndrome
• Others
Geographical Analysis:
By Geography, the market is segmented into:
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key Players:
• Vanda Pharmaceuticals*
• Takeda Pharmaceutical Company
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V
• Fitbit
• Koninklijke Philips
• Others
View full report: https://www.datamintelligence.com/research-report/circadian-rhythm-sleep-treatment-market
Download free sample: https://www.datamintelligence.com/download-sample/circadian-rhythm-sleep-treatment-market
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Circadian rhythm sleep disorders (CRSD) are sleep disorders which affect the timing of sleep. CRSDs arise from a persistent pattern of sleep/wake disturbances that can be caused either by dysfunction in one's biological clock system or by a misalignment between one's endogenous oscillator and externally imposed cues. The primary event in circadian rhythm sleep treatment is depression of melatonin level and irregular melatonin level during the circadian body clock.
Market Dynamics:
Increasing prevalence of sleep disorders is boosting the global circadian rhythm sleep treatment market. However, some side effects such as dizziness, headache, short-term feelings of depression, daytime sleepiness, stomach cramps, and irritability. These factors are hampering the global circadian rhythm sleep treatment market.
Market Segmentation:
By Treatment Type
• Light Therapy
• Drug Therapy
• Chronotherapy
By Disorder
• Delayed Sleep Phase Syndrome (DSPS)
• Advanced Sleep Phase Syndrome (ASPS)
• Irregular Sleep-Wake Disorder (ISWD)
• Non-24-h Sleep-Wake Syndrome
• Others
Geographical Analysis:
By Geography, the market is segmented into:
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key Players:
• Vanda Pharmaceuticals*
• Takeda Pharmaceutical Company
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V
• Fitbit
• Koninklijke Philips
• Others
View full report: https://www.datamintelligence.com/research-report/circadian-rhythm-sleep-treatment-market
Download free sample: https://www.datamintelligence.com/download-sample/circadian-rhythm-sleep-treatment-market
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results